Search - tctmd.com

Displaying 521 - 540 of 544

Sort: Relevancy | Date

News Daily News

Post-Conditioning Decreases Infarct Size, Edema after Reperfusion Therapy for STEMI

Leah Lawrence

June 05, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Yael L. Maxwell

June 01, 2012

News Industry News

ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent

May 15, 2012

News Daily News

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

Caitlin E. Cox

April 26, 2012

News Daily News

El Cierre del FOP contribuye a la Insaturación de Oxígeno Inducida por el Ejercicio

Jason Kahn

April 20, 2012

News Daily News

Radial PCI Cuts Deaths, Repeat Interventions in STEMI Patients

L.A. McKeown

March 23, 2012

News Daily News

Initial Transradial Learning Curve Not Harmful to Overall PCI Safety

Jason Kahn

March 22, 2012

News Daily News

Se Publica el CLOSURE I mientras siguen en Marcha Similares Ensayos del FOV

Caitlin E. Cox

March 15, 2012

News Daily News

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

L.A. McKeown

March 12, 2012

News Daily News

Los Expertos Eligen los Avances Más Importantes de 2011

Jason Kahn

March 08, 2012

News Daily News

Estudio se Centra en la Inflamación Sistémica tras la TAVR

Caitlin E. Cox

March 07, 2012

News Daily News

Los ACV secundarios a una PCI son Raros y se Asocian a Factores Operatorios Modificables

Yael L. Maxwell

March 06, 2012

News Daily News

Las Sociedades Recomiendan los Requisitos para el Programa TAVR

L.A. McKeown

March 06, 2012

News Daily News

El Cierre del FOP Puede Prevenir Episodios Cerebrovasculares Recurrentes

Yael L. Maxwell

March 06, 2012

News Industry News

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

February 29, 2012

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Industry News

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

November 02, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

Advertisement

Post-Conditioning Decreases Infarct Size, Edema after Reperfusion Therapy for STEMI

Watchman Works Just as Well Without Warfarin-Protected Transition

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

El Cierre del FOP contribuye a la Insaturación de Oxígeno Inducida por el Ejercicio

Radial PCI Cuts Deaths, Repeat Interventions in STEMI Patients

Initial Transradial Learning Curve Not Harmful to Overall PCI Safety

Se Publica el CLOSURE I mientras siguen en Marcha Similares Ensayos del FOV

El Apixaban Previene el ACV en Pacientes con Fibrilación Auricular con independencia de sus Antecedentes de ACV/AIT

Los Expertos Eligen los Avances Más Importantes de 2011

Estudio se Centra en la Inflamación Sistémica tras la TAVR

Los ACV secundarios a una PCI son Raros y se Asocian a Factores Operatorios Modificables

Las Sociedades Recomiendan los Requisitos para el Programa TAVR

El Cierre del FOP Puede Prevenir Episodios Cerebrovasculares Recurrentes

Boston Scientific Announces Launch of PROMUS Element™ Platinum Chromium Stent System in Japan

Hospital Readmission Post-PCI Linked to Increased Mortality

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content